GeneCentric Launches ExpressCT Rewind to Unlock Gene Expression from Liquid Biopsy Data
DURHAM, N.C., July 8, 2026 GeneCentric has announced the launch of ExpressCT Rewind™, a retrospective fragmentomics analysis service designed...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
DURHAM, N.C., July 8, 2026 GeneCentric has announced the launch of ExpressCT Rewind™, a retrospective fragmentomics analysis service designed...
SAN DIEGO, Calif., June 3, 2026 Zepto Life Technology has achieved a significant regulatory milestone after receiving U.S. Food...
PALO ALTO, Calif., May 13, 2026 DELFI Diagnostics announced that it will present the first-ever clinical utility data for...
MANHASSET, N.Y. — November 27, 2025: Feinstein Institutes for Medical Research, in collaboration with Stony Brook University and Texas...
YONGIN, South Korea — November 27, 2025: GC Genome has announced the publication of its landmark study on a...
